Vinorelbine and Gemcitabine in Myeloma

NCT02791373 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Amyloidosis

Interventions

DRUG: Vinorelbine
DRUG: Gemcitabine

Sponsor

Insel Gruppe AG, University Hospital Bern